Search Results - "Ranchon, F."

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin by Laplace, N., Kepenekian, V., Friggeri, A., Vassal, O., Ranchon, F., Rioufol, C., Gertych, W., Villeneuve, L., Glehen, O., Bakrin, N.

“…Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal…”
Get full text

Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases by Prely, H., Herledan, C., Caffin, A. G., Baudouin, A., Larbre, V., Maire, M., Schwiertz, V., Vantard, N., Ranchon, F., Rioufol, C.

“…Purpose Due to polypharmacy and the rising popularity of complementary and alternative medicines (CAM), oncology patients are particularly at risk of drug–drug…”
Get full text

Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study by Leclerc, V., Karlin, L., Herledan, C., Marchal, L., Baudouin, A., Gouraud, A., Caffin, A. G., Larbre, V., Lazareth, A., Bachy, E., Salles, G., Ghesquières, H., Rioufol, C., Ranchon, F.

“…Purpose The aim of this study is to assess international guidelines implementation concerning thromboprophylaxis strategy in myeloma patients treated with…”
Get full text

Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine by Larbre, V., Romain-Scelle, N., Reymond, P., Ladjouzi, Y., Herledan, C., Caffin, A. G., Baudouin, A., Maire, M., Maucort-Boulch, D., Ranchon, F., Rioufol, C.

“…Purpose The COVID-19 pandemic has disrupted healthcare access and telemedicine has been widely deployed. The aim of this study is to assess the impact of this…”
Get full text

Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients by Tixier, F., Ranchon, F., Iltis, A., Vantard, N., Schwiertz, V., Bachy, E., Bouafia‐Sauvy, F., Sarkozy, C., Tournamille, J. F., Gyan, E., Salles, G., Rioufol, C.

“…Optimal salvage chemotherapy regimen for patients with relapsed or refractory Hodgkin and non‐Hodgkin lymphoma remains unclear but often based on platinum…”
Get full text

Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review by Damaj, G, Cornillon, J, Bouabdallah, K, Gressin, R, Vigouroux, S, Gastinne, T, Ranchon, F, Ghésquières, H, Salles, G, Yakoub-Agha, I, Gyan, E

“…High-dose chemotherapy preceding autologous hematopoietic stem cell transplantation (auto-HSCT) is one treatment option for patients with Hodgkin (HL) or…”
Get full text

New treatments for cutaneous metastatic melanoma: MAPK pathway-targeted and immune based therapies by Ranchon, F, Boespflug, A, Rioufol, C, Schwiertz, V, Thomas, L, Dalle, S

“…Increasing knowledge on cellular biology has permitted rapid changes in the treatment of metastatic melanoma. Until 2011, dacarbazine was the gold standard…”
Get more information

Do systemic treatments delivered after Nivolumab result in better outcomes? A bicentric case-control study by Darrason, M., Chatelain, E., Ranchon, F., Gervaise, C., Duruisseaux, M., Couraud, S.

“…Immune checkpoint inhibitors (ICI) are now widely used at different stages of non-small cell lung cancers (NSCLC). Some clinical studies suggest that…”
Get full text

EPICC study: evaluation of pharmaceutical intervention in cancer care by Vantard, N., Ranchon, F., Schwiertz, V., Gourc, C., Gauthier, N., Guedat, M.-G., He, S., Kiouris, E., Alloux, C., You, B., Souquet, P.-J., Freyer, G., Salles, G., Trillet-Lenoir, V., Rioufol, C.

“…Summary What is known and objectives In cancer care, clinical pharmacists contribute to improving prevention and management of drug‐related problems (DRPs)…”
Get full text

SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors by Sarfati, L., Ranchon, F., Vantard, N., Schwiertz, V., Gauthier, N., He, S., Kiouris, E., Gourc-Berthod, C., Guédat, M. G., Alloux, C., Gustin, M.-P., You, B., Trillet-Lenoir, V., Freyer, G., Rioufol, C.

“…Summary What is known and objective Medication errors (ME) in oncology are known to cause serious iatrogenic complications. However, MEs still occur at each…”
Get full text

Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed? by Ranchon, F, Vantard, N, Gouraud, A, Schwiertz, V, Franchon, E, Pham, B N, Vial, T, You, B, Bouafia, F, Salles, G, Rioufol, C

“…We report a case of a potential drug-drug interaction in a woman treated by a first injection of high-dose methotrexate for a T-lymphoblastic lymphoma…”
Get more information

Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine by Larbre, V., Romain-Scelle, N., Reymond, P., Ladjouzi, Y., Herledan, C., Caffin, A., Baudouin, A., Maire, M., Maucort-Boulch, D., Ranchon, F., Rioufol, C.

Get full text

Clinical impact and cost-saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer by Herledan, Chloé, Falandry, Claire, Huot, Laure, Poletto, Nicolas, Baudouin, Amandine, Cerfon, Marie-Anne, Lorsche, Laurie, Bret, Judith, Ranchon, Florence, Rioufol, Catherine

“…Hospital admission and discharge are at high risk of drug-related problems (DRPs) in older patients with cancer. This study aimed to assess the clinical and…”
Get full text

SIOG2022-0141 - Contribution of a clinical pharmacist in a multidisciplinary assessment of older patients with cancer by Herledan, C., Cerfon, M.A., Baudouin, A., Ranchon, F., Falandry, C., Rioufol, C.

Get full text

Contribution of a clinical pharmacist in a multidisciplinary assessment of older patients with cancer by Herledan, C., Cerfon, M.A., Baudouin, A., Ranchon, F., Falandry, C., Rioufol, C.

Get full text

MEDICATION RECONCILIATION AND REVIEW TO PREVENT MEDICATION ERRORS IN ELDERLY CANCER PATIENTS by Herledan, C., Baudouin, A., Tracol, M., Garreau, R., Poletto, N., Ranchon, F., Rioufol, C.

Get full text

P052 - MEDICATION RECONCILIATION AND REVIEW TO PREVENT MEDICATION ERRORS IN ELDERLY CANCER PATIENTS by Herledan, C., Baudouin, A., Tracol, M., Garreau, R., Poletto, N., Ranchon, F., Rioufol, C.

Get full text

Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks by Hoegy, Delphine, Martin, Julie, Barral, Marine, Ranchon, Florence, Janoly-Dumenil, Audrey, Delande, Evariste, Pivot, Christine, Mouchoux, Christelle, Barral, M., Hoegy, D., Martin, J., Mouchoux, C., Pivot, C., Bréant, V., Dussart, C., Mandy, B., Rioufol, C., Aussedat, M., Bolon-Larger, M., Carpentier, I., Delande, E., Dode, X., Janoly-Dumenil, A., Goutelle, S., Bourguignon, L., Ranchon, F.

“…In the strained actual economic context, all clinical pharmacy activities cannot be achieved for all patients of all care pathways. So finding a way to…”
Get full text

Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks by Hoegy, Delphine, Martin, Julie, Barral, Marine, Ranchon, Florence, Janoly-Dumenil, Audrey, Delande, Evariste, Pivot, Christine, Mouchoux, Christelle, Barral, M., Hoegy, D., Martin, J., Mouchoux, C., Pivot, C., Bréant, V., Dussart, C., Mandy, B., Rioufol, C., Aussedat, M., Bolon-Larger, M., Carpentier, I., Delande, E., Dode, X., Janoly-Dumenil, A., Goutelle, S., Bourguignon, L., Ranchon, F.

“…Background: In the strained actual economic context, all clinical pharmacy activities cannot be achieved for all patients of all care pathways. So finding a…”
Get full text

How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)? by Barral, Marine, Martin, Julie, Carre, Emmanuelle, Janoly-Dumenil, Audrey, Ranchon, Florence, Parat, Stéphanie, Rioufol, Catherine, Goutelle, Sylvain, Bourguignon, Laurent, Novais, Teddy, Doh, Sebastien, Malatray, Matthieu, Chaudier, Philippe, Gauthier, Jerome, Pivot, Christine, Mouchoux, Christelle, Hoegy, Delphine

“…A new model was developed for integrating a personalised clinical pharmacy programme (5P project) into the orthogeriatric care pathway. To secure the…”
Get full text